How does BoomRx pricing become visible?

Three inputs generally shape the BoomRx rate displayed in your dashboard. First, the SKU mix — semaglutide, tirzepatide, peptides, hormones, and brand medications each carry different partner pharmacy costs across the 503A and 503B network. Second, expected volume, since BoomRx markets competitive network pricing that may improve as you scale. Third, the ancillary cost structure: whether the $30 flat cold-chain shipping fee per patient order, payment processing, or a platform fee are separate from the dashboard drug rate. Because none of these are published on boomrx.com, the same medication can price differently for different clinics, which is why written confirmation on your top SKUs matters more than a marketing headline.

Treat portal pricing as something to verify, not assume. Ask for per-vial cost in writing on your top three SKUs, ask whether that rate is fixed or changes at volume tiers, and ask what is included versus billed separately. A clear onboarding answer covers all three; a vague one leaves landed cost undefined until your first invoice.

Fizy Health inverts the timing problem. It shows resolved per-vial 503A cost on each catalog and cart line before checkout, with a separately disclosed facilitation fee at payment — no signup gate required to see a price on your top SKUs. That lets you run half of a pricing comparison immediately: read visible per-vial cost on semaglutide and tirzepatide, build a representative cart, and set that against whatever BoomRx shows after you complete provider signup.

Many clinics run that comparison on one refill week before choosing a primary workflow. The goal is not to skip BoomRx onboarding — it is to know what you are comparing against when portal rates finally appear.